- Home
- KBON vs AVTX Comparison
KBON vs AVTX Comparison
Compare KBON & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$16.22
Company Overview
Basic Information| Metric | KBON | AVTX |
|---|---|---|
| Founded | 2025 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 344.2M | 328.4M |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | KBON | AVTX |
|---|---|---|
| Price | $10.09 | $16.22 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $40.57 |
| AVG Volume (30 Days) | 26.2K | ★ 2.2M |
| Earning Date | 01-01-0001 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 72.07 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $27,813,137.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 2312.27 |
| 52 Week Low | $10.04 | $3.43 |
| 52 Week High | $10.15 | $24.27 |
Technical Indicators
Market Signals| Indicator | KBON | AVTX |
|---|---|---|
| Relative Strength Index (RSI) | 57.10 | 47.87 |
| Support Level | $10.05 | $13.70 |
| Resistance Level | $10.12 | $19.39 |
| Average True Range (ATR) | 0.01 | 1.98 |
| MACD | 0.00 | -0.36 |
| Stochastic Oscillator | 80.00 | 23.65 |
Price Performance
Historical Comparison KBON
AVTX
About KBON Karbon Capital Partners Corp. Class A Ordinary Shares
Karbon Capital Partners Corp is a blank check company.
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.